CSE:RVV - Post Discussion
Post by
Betteryear2 on Dec 18, 2023 8:40am
Revive Therapeutics Collaborates
TORONTO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has signed a collaboration agreement with Attwill Medical Solutions LP (“AMS”) for the clinical and commercial development of the Company’s next-generation lyophilized formulation of Bucillamine. Revive Therapeutics Collaborates with Attwill Medical (globenewswire.com)
Be the first to comment on this post